A Win For Mustang Bio, Inc.
Mon, Jun 17, 2024 at 07:12 PM
Mustang Bio, Inc. (MBIO:NASDAQ) rocketted at $0.75, representing a gain of 476.9%. On Mon, Jun 17, 2024, MBIO:NASDAQ touched a New 2-Week High of $0.75. The stock appeared on our News Catalysts scanner on Mon, Jun 17, 2024 at 04:20 PM in the 'AGREEMENT' category. From Mon, Jun 03, 2024, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Mon, Jun 17, 2024 at $0.97 with a volume of 1B+.
About Mustang Bio, Inc. (MBIO:NASDAQ)
Mustang Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to eliminate cancer cells.
Top 10 Gainers:
- Mustang Bio, Inc. (MBIO:NASDAQ), 476.92%
- Movella Holdings Inc Com (MVLA:NASDAQ), 75.83%
- Interactive Strength Inc. (TRNR:NASDAQ), 71.33%
- Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI:NASDAQ), 60.46%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 60%
- Azitra Inc (AZTR:NYSEMKT), 56.53%
- Unico American Corporation (UNAM:NASDAQ), 50%
- Trxade Group, Inc. (MEDS:NASDAQ), 41.28%
- Xponential Fitness Inc. Class A (XPOF:NYSE), 34.25%
- ENDRA Life Sciences Inc. (NDRA:NASDAQ), 34.17%